睿知中国疾病研究地图
候选清单0

合肥

安徽中医药大学第一附属医院

First Affiliated Hospital of Anhui University of Chinese Medicine

在本站收录的 53 种疾病中,这家医院列在其中 3 种下,依据是它牵头的研究论文,以及它作为牵头方或研究中心登记的试验。

这里展示的是公开记录中的研究活动,不是医疗水平评级。能否为某位患者提供帮助,应由医院和主治医生判断。

这家医院的官网还没有核对。

联系这家医院

安徽中医药大学第一附属医院的研究

选择一种疾病,查看背后的论文和试验。 每个方块显示 2021–2025 年牵头的论文数和每年的数量。

只包括本站收录的 53 种疾病。未列出某种疾病,表示在这些记录中这家医院没有达到该病的列出标准,不代表它不诊治该病。 哪些医院会被列出

  1. 肝豆状核变性Wilson disease52 篇牵头论文
  2. 肌萎缩侧索硬化症Amyotrophic lateral sclerosis2 篇牵头论文
  3. IgA 肾病IgA nephropathy5 篇牵头论文

未列出的收录疾病:鼻咽癌、食管鳞状细胞癌、肝细胞癌、胃癌、肝母细胞瘤、视网膜母细胞瘤、脊索瘤、骨肉瘤、胃肠道间质瘤、神经母细胞瘤、尤文肉瘤、多发性骨髓瘤、B 细胞急性淋巴细胞白血病、再生障碍性贫血、噬血细胞性淋巴组织细胞增生症、β 地中海贫血、血友病 A、非典型溶血性尿毒症综合征、血栓性血小板减少性紫癜、范可尼贫血、视神经脊髓炎谱系疾病、IgG4相关性疾病、重症肌无力、烟雾病、胆道闭锁、抗 NMDA 受体脑炎、大动脉炎、肝包虫病、特发性肺纤维化、肺淋巴管平滑肌瘤病、脊髓性肌萎缩症、法布雷病、庞贝病、杜氏肌营养不良、白塞病、Alport 综合征、戈谢病、尼曼-匹克病 C 型、成骨不全症、原发性胆汁性胆管炎、原发性硬化性胆管炎、先天性膈疝、先天性巨结肠、遗传性大疱性表皮松解症、遗传性血管性水肿、家族性腺瘤性息肉病、Leber 遗传性视神经病变、Majeed 综合征、NGLY1 缺乏症、ISG15 缺乏症。

其他疾病

肝豆状核变性

Wilson disease

2021–2025 年中国大陆作者发表的 201 篇肝豆状核变性 PubMed 英文论文中,这家医院牵头了 52 篇,占 25.9%。

牵头论文
52
2021–2025 年
牵头试验
1
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 4420212022: 4420222023: 111120232024: 181820242025: 14142025

合肥有 4 家医院列在肝豆状核变性下全国有 28 家医院列在肝豆状核变性下

截至 2026年11月8日,ClinicalTrials.gov 上没有列出这家医院的肝豆状核变性开放试验。

这些数字背后的记录
研究主题遗传学(ATP7B)诊断与铜代谢检测肝病与肝移植
论文中的科室神经内科影像/核医学科临床试验/研究机构普外/肝胆胰外科
牵头的论文52
  1. Melatonin ameliorates copper accumulation-induced cognitive impairment in Wilson disease via activation of the SIRT3/FOXO3α signaling pathway.2026Neuropharmacology
  2. Oral Engineered Extracellular Vesicles Based on Ion Exchange Strategy for Multipronged Management of Wilson's Disease Complicated with Reproductive Dysfunction Therapy.2025Advanced science (Weinheim, Baden-Wurttemberg, Germany)免费全文
  3. Risk factors and prediction model development for pancreatic fistula following splenectomy in Wilson's disease patients with portal hypertension.2025BMC gastroenterology免费全文
  4. Ultrasound-derived fat fraction: a novel approach for assessing Wilson's disease-related hepatic steatosis.2025BMC gastroenterology免费全文
  5. Social Support, Self-Management Behaviors, and Coping Styles of Patients With Wilson's Disease: A Quantitative Empirical Research.2025Brain and behavior免费全文
  6. Transcriptional specialization shapes abnormal cortical morphological similarity gradients in Wilson's disease.2025Brain research
  7. Application of Anterior Segment Optical Coherence Tomography in Detecting Kayser-Fleischer Rings in Wilson Disease.2025Cornea免费全文
  8. Review of the Efficacy and Mechanisms of Traditional Chinese Medicine for Treating Multi-Organ Damage in Wilson's Disease.2025Drug design, development and therapy免费全文
  9. Development and validation of a nomogram model for prediction of dyslipidemia in children with Wilson disease: a retrospective analysis.2025Frontiers in endocrinology免费全文
  10. Role and mechanisms of cuproptosis in the pathogenesis of Wilson's disease (Review).2025International journal of molecular medicine免费全文
  11. Revolutionizing Wilson disease prognosis: a machine learning approach to predict acute-on-chronic liver failure.2025Journal of translational medicine免费全文
  12. Mechanistic Insights Into GDFMD-Mediated Inhibition of Liver Fibrosis via miRNA-29b-3p Upregulation in Wilson's Disease.2025Mediators of inflammation免费全文
  13. Analysis of factors affecting early hepatic steatosis in pediatric patients with Wilson's disease in China: A retrospective study.2025Medicine免费全文
  14. Safety of penicillamine and trientine in the treatment of Wilson's disease: An analysis of the FDA Adverse Event Reporting System (FAERS) database.2025PloS one免费全文
  15. Evaluation of salivary ceruloplasmin for the diagnosis of Wilson's disease.2025Scientific reports免费全文
  16. Construction of a nomogram for predicting compensated cirrhosis with Wilson's disease based on non-invasive indicators.2024BMC medical imaging免费全文
  17. Copper exposure induces inflammation and PANoptosis through the TLR4/NF-κB signaling pathway, leading to testicular damage and impaired spermatogenesis in Wilson disease.2024Chemico-biological interactions
  18. Gandouling ameliorates liver injury in Wilson's disease through the inhibition of ferroptosis by regulating the HSF1/HSPB1 pathway.2024Journal of cellular and molecular medicine免费全文
  19. Gandouling induces GSK3β promoter methylation to improve cognitive impairment in Wilson's disease.2024Journal of ethnopharmacology
  20. Berberine alleviates ovarian tissue damage in mice with hepatolenticular degeneration by suppressing ferroptosis and endoplasmic reticulum stress.2024Journal of integrative medicine
  21. Relative exchangeable copper, a high-quality biomarker for differentiation of Traditional Chinese Medicine syndrome in Wilson's disease.2024Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan免费全文
  22. Characterization of renal damage in Wilson's disease-Detailed analysis of 20 Chinese cases.2024Medicina clinica
  23. A clinical study showing the expression characteristics of cuproptosis markers in cases with Wilson disease.2024Medicine免费全文
  24. Discussion on the relationship between the distribution characteristics of TCM syndrome types and related objective indicators in hepatolenticular degeneration.2024Medicine免费全文
  25. Network pharmacology-based approach to understand the effect and mechanism of chrysophanol against cognitive impairment in Wilson disease.2024Metabolic brain disease
  26. Transcriptomic evaluation of N6-methyladenosine modification can be used to identify differentially gene and immune-related biological processes in TX mice with liver fibrosis.2024Molecular biology reports
  27. Identification of lncRNA-miRNA-mRNA Networks in the Lenticular Nucleus Region of the Brain Contributes to Hepatolenticular Degeneration Pathogenesis and Therapy.2024Molecular neurobiology免费全文
  28. From Wilson's Disease to Neurodevelopmental Disorder with Involuntary Movements, Different Genetic Interpretations in a Female Patient.2024Movement disorders : official journal of the Movement Disorder Society
  29. Abnormalities in subcortical function and their treatment response in Wilson's disease.2024NeuroImage. Clinical免费全文
  30. Serum ceruloplasmin oxidase activity: A neglected diagnostic biomarker for Wilson disease.2024Parkinsonism & related disorders
  31. Assessment and factors affecting quality of life among patients with Wilson's disease.2024Scientific reports免费全文
  32. 1H-NMR-based metabolomics to dissect the traditional Chinese medicine promotes mesenchymal stem cell homing as intervention in liver fibrosis in mouse model of Wilson's disease.2024The Journal of pharmacy and pharmacology
  33. NK cell exhaustion in Wilson's disease revealed by single-cell RNA sequencing predicts the prognosis of cholecystitis.2024eLife免费全文
  34. Application of attenuation coefficient in the assessment of hepatic involvement in children and adolescents with Wilson's disease.2023BMC medical imaging免费全文
  35. Large-scale networks changes in Wilson's disease associated with neuropsychiatric impairments: a resting-state functional magnetic resonance imaging study.2023BMC psychiatry免费全文
  36. Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.2023Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  37. Gandouling alleviates nerve injury through PI3K/Akt/FoxO1 and Sirt1/FoxO1 signaling pathway to inhibit autophagy in the rats model of Wilson's disease.2023Brain and behavior免费全文
  38. Integrated Metabolomics and Network Pharmacology to Reveal the Mechanisms of Gandouling Tablets Against Copper-Overload-Induced Neuronal Injury in Rats with Wilson's Disease.2023Drug design, development and therapy免费全文
  39. A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson's disease.2023Expert review of vaccines
  40. 1H NMR-based metabolomic study of striatal injury in rats with copper-loaded Wilson's disease by Chinese and Western medicine intervention.2023Journal of pharmaceutical and biomedical analysis
  41. Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson's Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification.2023Mediators of inflammation免费全文
  42. Comprehensive analysis of the coding and non-coding RNA transcriptome expression profiles of hippocampus tissue in tx-J animal model of Wilson's disease.2023Scientific reports免费全文
  43. Changes in Hepatic Function After Splenectomy for Hepatolenticular Degeneration, Cirrhosis, and Hypersplenism.2023The American surgeon
  44. Lesions in White Matter in Wilson's Disease and Correlation with Clinical Characteristics.2023The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
  45. Nomogram for prediction of portal vein system thrombosis after splenectomy for hypersplenism in patients with Wilson disease.2022Annals of palliative medicine
  46. Liver stiffness assessed by real-time two-dimensional shear wave elastography predicts hypersplenism in patients with Wilson's disease: a prospective study.2022BMC medical imaging免费全文
  47. Copper deposition in Wilson's disease causes male fertility decline by impairing reproductive hormone release through inducing apoptosis and inhibiting ERK signal in hypothalamic-pituitary of mice.2022Frontiers in endocrinology免费全文
  48. Clinical and genetic characterization of a large cohort of patients with Wilson's disease in China.2022Translational neurodegeneration免费全文
  49. Platelet safety range before splenectomy for hypersplenism: based on 244 cases of splenectomy in hepatolenticular degeneration patients.2021Acta gastro-enterologica Belgica
  50. GanDouLing promotes proliferation and differentiation of neural stem cells in the mouse model of Wilson's disease.2021Bioscience reports免费全文
  51. Cirrhosis of Wilson's disease: High and low cutoff using acoustic radiation force impulse (ARFI) -Comparison and combination with serum fibrosis index.2021Clinical hemorheology and microcirculation
  52. Differentially expressed lncRNAs in liver tissues of TX mice with hepatolenticular degeneration.2021Scientific reports免费全文
中文论文(未计入)6
  1. [LncRNA Meg3 expression level is negatively correlated with liver fibrosis severity in patients with Wilson disease].2025Nan fang yi ke da xue xue bao = Journal of Southern Medical University免费全文
  2. [Gandou Fumu Decoction improves liver steatosis by inhibiting hepatocyte ferroptosis in mice with Wilson's disease through the GPX4/ACSL4/ALOX15 signaling pathway].2025Nan fang yi ke da xue xue bao = Journal of Southern Medical University免费全文
  3. [Gandou Bushen Decoction Ameliorates Cognitive Impairment in Wilson Disease Model TX Mice by Regulating Melatonin Synthesis via the SIRT3/FOXO3α Pathway].2025Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition免费全文
  4. [Analysis of clinical phenotype and ATP7B variants characteristics of 337 patients with hepatolenticular degeneration in Anhui province].2025Zhonghua yi xue za zhi
  5. [Gandou Bushen Decoction improves spermatogenesis and promotes spermatogenic cell proliferation in Wilson disease TX mice by activating testicular ERK signaling pathway].2024Nan fang yi ke da xue xue bao = Journal of Southern Medical University免费全文
  6. [Huangpu Tongqiao Capsule improves cognitive impairment in rats with Wilson disease by inhibiting endoplasmic reticulum stress-mediated apoptosis pathway].2024Nan fang yi ke da xue xue bao = Journal of Southern Medical University免费全文
它在 ClinicalTrials.gov 上的全部试验(任何状态)1
  1. The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease已完成NCT06762509牵头方2016-12 启动

打开 PubMed 检索ClinicalTrials.gov

其他疾病

肌萎缩侧索硬化症

Amyotrophic lateral sclerosis

2021–2025 年中国大陆作者发表的 779 篇肌萎缩侧索硬化症 PubMed 英文论文中,这家医院牵头了 2 篇,占 0.3%。

牵头论文
2
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 0020212022: 0020222023: 1120232024: 1120242025: 002025

合肥有 2 家医院列在肌萎缩侧索硬化症下全国有 194 家医院列在肌萎缩侧索硬化症下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的肌萎缩侧索硬化症开放试验。

这些数字背后的记录
论文中的科室神经内科
牵头的论文2
  1. Genetic causal role of body mass index in multiple neurological diseases.2024Scientific reports
  2. A patient carrying a heterozygous p.Asn267Ser TARDBP missense mutation diagnosed as ALS and only involving lower motor neurons.2023Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
中文论文(未计入)1
  1. [Clinical analysis of a motor neuron disease-like phenotype associated with anti-IgLON5 disease].2025Zhonghua nei ke za zhi

打开 PubMed 检索ClinicalTrials.gov

其他疾病

IgA 肾病

IgA nephropathy

2021–2025 年中国大陆作者发表的 736 篇IgA 肾病 PubMed 英文论文中,这家医院牵头了 5 篇,占 0.7%。

牵头论文
5
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 0020212022: 0020222023: 0020232024: 0020242025: 442025

合肥有 4 家医院列在IgA 肾病下全国有 346 家医院列在IgA 肾病下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的IgA 肾病开放试验。

这些数字背后的记录
论文中的科室肾内科

这些论文过半是实验室或动物研究。

打开 PubMed 检索ClinicalTrials.gov

联系这家医院

出示给工作人员或司机的院名卡

安徽中医药大学第一附属医院

First Affiliated Hospital of Anhui University of Chinese Medicine

合肥

大医院往往有多个院区,出发前请先向医院确认院区。

中英对照的咨询信

填写方括号中的内容后,通过医院国际医疗部或官网上的联系方式发送。在这里输入的内容不会离开您的设备。

医院通常需要的资料

  • 主治医生近期的病情总结或信件
  • 病理报告
  • 影像检查(CT、MRI、PET)及报告,尽量附影像文件
  • 已接受的治疗及时间
  • 目前用药

下一步建议

与主治医生沟通可将本页分享给主治医生,一同评估该团队的研究方向是否相关。
确认团队现状论文发表通常滞后数月,医生也可能调动。请在医院官网查询相关科室。
直接联系医院请通过医院官方公布的渠道联系。医院不向我们支付任何费用;是否接诊由医院决定。

这些数字从哪里来

论文

2021–2025 年 PubMed 英文论文中,第一作者或最后作者的第一单位是这家医院的论文。 定义

试验

ClinicalTrials.gov 上列出这家医院为牵头方或研究中心的记录,截至 2026年11月8日。

编号与其他名称

没有匹配到医院级的 ROR 记录。

提出更正下载数据